“…To enable our FRET approach, into each Cys-less subunit, standard site-directed mutagenesis techniques were used to install a single Cys in place of the residue that, on the basis of sequence alignments and modeling (McMurray & Thorner, 2008) against the crystal structure of the human septin complex (Sirajuddin et al, 2007), should occupy a solvent-exposed position at the base of the predicted C-terminal extension (CTE) in Cdc11, Cdc12, Cdc3, and Shs1, and near the carboxyl terminus of Cdc10 (which is the only mitotic septin that lacks a CTE), yielding Cdc11(E294C), Cdc12(L310C), Cdc3(S407C), Shs1(E344C), and Cdc10(R298C) (Booth et al, 2015; de Val et al, 2013). By placing a single Cys at this location, it should be sufficiently accessible for efficient dye labeling, and the resulting conjugated fluorophore would be close to the globular GTP-binding domain and relatively free from constraints on its rotation.…”